> Research Use Only Disclaimer: All products discussed in this article are sold strictly for laboratory research and scientific purposes. They are not approved for human consumption, clinical use, or veterinary application. Always consult applicable regulations before handling research compounds.
NuScience Peptides has emerged as one of the more analytically rigorous research peptide suppliers serving the U.S. market. With 62 active product listings, a catalog spanning modern GLP-1 receptor agonists through established healing peptides, and a quality infrastructure anchored in third-party HPLC and mass spectrometry testing, NuScience occupies an interesting middle tier in the supplier landscape — sitting between minimalist catalog operators and the fully branded, tier-one suppliers with Trustpilot footprints and verified status.
This review draws on Peptides.SO listing data, independent testing records from Finnrick (48 tests across 10 peptides), and Peptide Grades' vendor-level evaluation to give researchers an objective picture of what NuScience delivers — and where it falls short — in 2026.
Company Background
NuScience Peptides LLC is a North Carolina-registered company with a USPTO trademark, public ownership (identified as Joseph DeRosa), and a listing in the NC Biotech Center directory. That combination of state registration, trademark documentation, and biotech sector visibility puts NuScience in a narrower subset of research peptide suppliers that carry verifiable corporate identity — a meaningful differentiation in a market where anonymous operations are common.
The company positions itself around scientific innovation and what it calls a "science-forward" approach to the research peptide supply chain. In practice, this manifests in the breadth and modernity of its catalog — NuScience was among the earlier retail suppliers to stock newer-generation dual-agonist compounds like Cagrilintide and Survodutide alongside the established GHRH/GHRP analog set.
NuScience operates exclusively in the U.S. domestic market, with no listed international shipping program, which is standard among American suppliers at this tier. Orders ship from within the U.S., which eliminates customs exposure and the peptide degradation risk associated with long international transit times.
Catalog Depth and Breadth
NuScience's 62 active Peptides.SO listings span five major research compound categories, giving it one of the more diversified catalogs in the mid-tier supplier segment.
Growth Hormone Secretagogues
The GH-axis coverage is comprehensive: CJC-1295 (both with and without DAC), Ipamorelin, GHRP-2, GHRP-6, Hexarelin, Sermorelin, and MK-677 (Ibutamoren). Pre-blended stacks are also available — notably the CJC-1295/Ipamorelin combination vial and a GHRP-2/Ipamorelin stack — which reflects operational sophistication in blend formulation. Tesamorelin, an FDA-approved GHRH analog studied in visceral adiposity research, rounds out the secretagogue section.
GLP-1 Receptor Agonists and Metabolic Compounds
This is where NuScience's catalog most clearly reflects 2025–2026 trends in research compound demand. Semaglutide and Tirzepatide (the dual GIP/GLP-1 agonist) are core listings. More advanced entries include Cagrilintide (an amylin analog studied in combination with Semaglutide in the CagriSema trials), Survodutide (GLP-1/glucagon dual agonist studied in NASH/metabolic disease), and Mazdutide — demonstrating genuine catalog ambition beyond basic GLP-1 coverage.
The GLP-3 RT product (Retatrutide) is listed as well. Retatrutide is Eli Lilly's triple GIP/GLP-1/glucagon agonist currently in Phase 3 trials (LY3437943), authorized for research-profile content by CEO directive (PEP-1484, August 2026).
Tissue Repair and Healing Peptides
BPC-157 and TB-500 are both individually listed and available in pre-blended formulations — including the popular BPC-157/TB-500 combination vial (20mg blend). A four-compound immune research blend (Thymosin Alpha-1, TB-4, BPC-157, and KPV) demonstrates interest in multi-compound convenience formats. AOD-9604 rounds out the metabolic/healing subcategory.
Bioregulators
NuScience carries an unusually extensive bioregulator section for a mid-tier supplier. Epithalon, Thymalin, Cardiogen, Livagen, Ovagen, Pinealon, Prostamax, Testagen, and Vesugen are all listed — covering the major Khavinson peptide bioregulator series studied in aging biology, immune regulation, cardiac function, and tissue specificity research. This depth in bioregulators is a catalog differentiator; many competitors offer at most Epithalon and Thymalin.
Melanocortin Peptides
Melanotan I, Melanotan II, and PT-141 (Bremelanotide — FDA-approved as Vyleesi for hypoactive sexual desire disorder) are all listed, covering the melanocortin receptor ligand space from pigmentation to CNS signaling research.
Cognitive and Nootropic Peptides
Semax and Selank are both available, covering neuroprotective and anxiolytic-adjacent research domains. Cerebrolysin (60mg) — a neurotrophin-rich peptide compound studied in neurodegenerative disease models — is a more unusual catalog entry that signals genuine breadth.
Specialty and Longevity Compounds
GHK-Cu is available in multiple formats: standard powder vial (100mg/10 vials), a 3% topical serum, and a GHK-Cu/KPV combination. Thymosin Alpha-1 covers immune function and immune modulation research. MOTS-c (a mitochondria-derived peptide), SS-31 (mitochondrial protective peptide), FOXO4-DRI (a senolytic peptide studied in cellular senescence), and PNC-27 (an anticancer peptide candidate) round out the longevity/advanced research segment. 5-Amino-1MQ (a NNMT inhibitor) and NAD+ peptide (1000mg) expand into the metabolic longevity compound space.
Accessory products include BAC water (2ml–10ml), Glutathione, VIP (Vasoactive Intestinal Peptide), and DSIP sleep research spray — indicating attention to the ancillary research support products that customers regularly purchase alongside peptide compounds.
COA Standards and Testing Quality
COA documentation is the most operationally critical differentiator among research peptide suppliers, and NuScience's approach reveals both strengths and a meaningful gap.
Strengths: NuScience publishes Certificates of Analysis for each product batch, with purity percentages, molecular weight confirmation, and batch traceability. Testing is performed using HPLC (High-Performance Liquid Chromatography) and mass spectrometry — the gold standard analytical methods for peptide purity verification. COAs are accessible through the supplier's website before purchase, allowing researchers to pre-verify documentation quality.
The Transparency Gap: NuScience's COAs do not name the third-party laboratory conducting the analysis. The certificates identify testing as independent third-party verification but omit the lab's identity — meaning researchers cannot independently contact the lab to verify batch-specific findings. This contrasts with the highest-transparency suppliers, who name their testing labs directly on certificates, enabling full independent confirmation.
This gap is meaningful in scientific research contexts but is consistent with mid-tier supplier practice. NuScience is substantially above the bottom of the disclosure spectrum (self-reported manufacturer claims with no third-party testing) but has not reached the verification standard of the top-transparency vendors.
Independent Testing Results (Finnrick Dataset): Finnrick's independent peptide testing program has logged 48 tests across 10 NuScience peptides spanning April 2025 through February 2026. The results are product-specific:
- •Tirzepatide: A rating (Great) — 6 samples tested, latest January 15, 2026. Consistent scores with averages above 7/10.
- •Retatrutide: A rating (Great) — 8 samples tested, latest February 13, 2026. Testing spanned April 2025 to February 2026, with purity improving from 93–95% in early tests to 99.90% in the most recent batch — indicating meaningful QC improvement over time.
- •Semaglutide: B rating (Good) — 14 samples tested, latest September 2025. The most extensively independently tested NuScience product; no score below 5.0. One 20mg sample showed -17.3% dose variance while still testing at 99.94% purity — a fill-accuracy note worth monitoring.
- •GHK-Cu: Tentative A rating — 2 samples tested, strong results but low sample count.
- •Ipamorelin: Tentative D rating (Poor) — 2 samples tested. Low sample count limits certainty, but the data point warrants caution on this specific compound until more tests accumulate.
Peptide Grades' comprehensive evaluation scores NuScience at 4.5/5 based on 47 independently tested samples, with a vendor-level average of 7.1/10 — placing NuScience in the upper tier of independently evaluated suppliers.
Pricing Analysis
NuScience's pricing structure is oriented around a permanent-sale model: products are listed at a base price with a consistently applied discounted price. Representative 2026 pricing from Peptides.SO listings:
| Compound | Standard Size | Discounted Price | Price/mg |
|---|---|---|---|
| BPC-157 | 5mg | $34.99 | ~$7.00/mg |
| TB-500 | 5mg | $39.99 | ~$8.00/mg |
| CJC-1295 (No DAC) | 5mg | $42.99 | ~$8.60/mg |
| Ipamorelin | 5mg | $39.99 (GHRP-2 stack) | ~$8.00/mg |
| Semaglutide | 5mg | $79.99 | ~$16.00/mg |
| Tesamorelin | 10mg | $54.99 | ~$5.50/mg |
| Epithalon | 10mg | $44.99 | ~$4.50/mg |
| GHK-Cu | 200mg (10 vials) | $44.99 | ~$0.22/mg |
| Semax | 10mg | $34.99 | ~$3.50/mg |
| Selank | 10mg | $44.99 | ~$4.50/mg |
| Hexarelin | 2mg | $19.99 | ~$10.00/mg |
| Melanotan I | 10mg | $29.99 | ~$3.00/mg |
| Cagrilintide | 10mg | $74.99 | ~$7.50/mg |
| Tirzepatide | 10mg | $121.99 | ~$12.20/mg |
| Retatrutide | 1mg | $89.00 | ~$89.00/mg |
NuScience's pricing is competitive within the mid-tier supplier range. The BPC-157 pricing (~$7/mg) is in the middle of the market. The Semaglutide pricing (~$16/mg at 5mg) is strong on value for this compound. Retatrutide pricing reflects its scarcity position as a Phase 3 compound not widely available.
NuScience does not appear to publish a formal discount code program, though the permanent price reduction visible on most product pages effectively functions as a continuous promotional pricing structure. Free shipping is available on U.S. orders exceeding $200, and payment by check is accepted — an unusual option that may be useful for institutional purchasers.
Shipping and Packaging
NuScience offers same-day shipping on orders placed before 12 PM EST, using insulated packaging with cold packs when required for temperature-sensitive compounds. Standard shipping is U.S. domestic only, which eliminates the dual risks of international customs inspection and extended transit degradation for peptide stability.
Customer experience reports note that when fulfillment issues arise, the NuScience team has directly intervened — handling insurance claims for lost packages, issuing replacements, and upgrading shipping methods proactively. The company is described in customer accounts as responsive by phone, which is becoming an increasingly rare service standard in the online research compound market.
NuScience relies on customers to know the import regulations of their own regions. While the supplier ships only domestically, researchers should be aware that international forwarding or re-shipment falls outside the company's responsibility framework.
Customer Experience
NuScience maintains no Trustpilot presence that Peptides.SO has indexed, and its formal review count on the platform is minimal. This means the customer experience picture is drawn primarily from forum discussions and the independent testing aggregators rather than formal review platforms.
Across the available feedback, consistent themes emerge: strong order accuracy, fast fulfillment for in-stock items, and customer service that engages directly with issues rather than routing to automated responses. The company's direct phone accessibility is repeatedly cited as a differentiator.
The absence of a Trustpilot footprint is itself a data point. Some research-focused suppliers deliberately avoid consumer review platforms as a risk management measure; others simply haven't prioritized it. Either way, researchers used to verifying vendors through aggregated consumer reviews will find NuScience's social proof infrastructure lighter than peers like Ameano Peptides or Royal Peptides.
Peer Comparison
In the context of the Peptides.SO supplier ecosystem, NuScience compares favorably with its category peers on catalog depth and testing rigor, but its verification status (unverified on Peptides.SO), minimal review footprint, and anonymous COA labs represent structural gaps relative to the platform's top-tier suppliers.
Vs. Ameano Peptides (72+ listings): Ameano offers more extensive metabolic compound coverage and a stronger review infrastructure. NuScience counters with broader bioregulator depth and a more evident QC improvement trajectory in independent testing data.
Vs. Liberty Peptides: Liberty has Trustpilot presence and a longer operational track record. NuScience's catalog is substantially broader in the current (2026) research compound landscape, particularly in next-generation metabolic compounds.
Vs. Modern Research Peptides: Catalog size is similar. NuScience differentiates on bioregulator depth and independent testing volume.
Pros and Cons
Strengths
- •Verifiable corporate identity: NC-registered LLC with USPTO trademark and public ownership — meaningful trust signal in an anonymous market
- •GLP-1 compound strength: Grade A ratings for Tirzepatide and Retatrutide from independent testing; strong Semaglutide volume with no tests below 5.0
- •Bioregulator depth: Comprehensive Khavinson bioregulator coverage rare in this supplier tier
- •Modern catalog: Next-generation metabolic compounds (Cagrilintide, Survodutide, Mazdutide) reflect active catalog maintenance
- •Responsive customer service: Direct phone access and intervention on fulfillment issues
- •Same-day shipping: Orders before 12 PM EST fulfill same business day
Limitations
- •Anonymous COA labs: Third-party testing claimed but testing lab not named on certificates
- •Ipamorelin weakness: Tentative D rating from Finnrick (2 samples) warrants caution until more data accumulates
- •No Trustpilot presence: Limited formal review infrastructure compared to peers
- •Unverified status on Peptides.SO: No platform verification badge
- •No international shipping: U.S.-only operation limits researcher access
- •Permanent-sale pricing model: Base prices are inflated; the "sale" prices are the real pricing
Final Verdict
NuScience Peptides earns a recommended rating for researchers focused on GLP-1 compounds, bioregulators, and metabolic research peptides. The combination of verifiable corporate identity, consistent GLP-1 performance in independent testing (Tirzepatide and Retatrutide both Grade A), extensive bioregulator catalog depth, and responsive customer service creates a credible research supply option in the mid-tier supplier segment.
The primary caution areas are compound-specific: independent testing has flagged Ipamorelin at a tentative D rating, and the unnamed COA lab represents a transparency gap relative to the most rigorous suppliers on the market. Researchers sourcing secretagogue peptides — particularly Ipamorelin — should consider requesting additional batch documentation or sourcing that specific compound from a supplier with stronger independent testing on that product.
For the GLP-1 receptor agonist category specifically, NuScience presents a strong value proposition: Grade A independent testing on Tirzepatide and Retatrutide, competitive per-mg pricing, same-day domestic fulfillment, and a QC trajectory showing measurable purity improvement over time.
---
All products mentioned in this review are for laboratory research and scientific investigation purposes only. They are not approved for human consumption, clinical use, or veterinary application. Peptides.SO does not endorse any specific supplier. Conduct appropriate due diligence before making research compound purchasing decisions.